Virus Inactivation in the 1990's ? and into the 21st Century. Part 1: Skin, Bone, and Cells

July 15, 2002
Gail Sofer

Volume 15, Issue 7

by Gail Sofer, BioReliance Viruses present dangers (and therefore challenges) to biopharmaceutical manufacturing processes. The virus inactivation method chosen depends on the virus and its surrounding medium. This survey article, organized by sample type, lists viral inactivation methods published during the past decade. Part 1 presents data for skin and bone and for cells that are not platelets or blood cells.